Results 111 to 120 of about 7,331 (198)

Risk-benefit assessment of ivabradine in the treatment of chronic heart failure

Drug, Healthcare and Patient Safety, 2014
Irmina Urbanek, Krzysztof Kaczmarek, Iwona Cygankiewicz, Pawel PtaszynskiDepartment of Electrocardiology, Chair of Cardiology and Cardiosurgery, Medical University, Lodz, PolandAbstract: Heart rate is not only a major risk marker in heart failure but ...
Urbanek I, Kaczmarek K, Cygankiewicz I, Ptaszynski P   +3 more
doaj  

Ivabradine for Incessant Atrial Tachycardia in a 1-Year-Old Child After Tetralogy of Fallot Repair

Case Reports in Cardiology
Discussion: Ivabradine may be an option for incessant atrial tachycardia in pediatric patients. Although most tachyarrhythmias following TOF repair occur due to a reentry mechanism, focal mechanisms can also occur, suggested by timing, gradual ...
Haikal Balweel, Rubiana Sukardi, Eva Miranda Marwali, Rifqi Rizkani Eri, Novaro Adeneur Tafriend, Agus Harsoyo   +5 more
doaj   +1 more source

Comparison of endothelial function in patients with Stage I-II arterial hypertension and stable angina, receiving various bradycardic agents and perindopril

Кардиоваскулярная терапия и профилактика, 1970
Aim. To compare endothelial function in patients with Stage I-II arterial hypertension (AH) and Functional Class (FC) II stable angina, receiving either beta-adrenoblocker (metoprolol tartrate) or If channel inhibitor (ivabradine), combined with ...
L. L. Kirichenko, A. N. Golosova, S. V. Gatsura, A. P. Korolev, K. V. Ovsyannikov, P. V. Struchkov   +5 more
doaj  

Ivabradine (Procoralan) [PDF]

, 2008
peer reviewedIvabradine (Procoralan), a new If inhibitor which acts specifically and in a dose-dependent manner on the pacemaker activity of the sinoatrial node, is a pure heart rate lowering agent.
LANCELLOTTI, Patrizio
core  

Investigation of Bicarphen and Ivabradine crystalline forms

, 2017
Bikarfēna un ivabradīna kristālisko formu izpēte. Borisova A., zinātniskais vadītājs Dr. ķīm., prof. Andris Actiņš. Maģistra darbs, 60 lpp., 19 attēli, 7 tabulas, 46 literatūras avoti, 2 pielikumi.
Borisova, Anastasija
core  

PR Interval as a Novel Therapeutic Target of Ivabradine Therapy—Prognostic Impact of Ivabradine-Induced PR Prolongation in Heart Failure Patients

Background: Ivabradine reduces heart rate by inhibiting the “funny current” expressed on the sinoatrial node and improves mortality and morbidity in patients with systolic heart failure and sinus tachycardia.
Toshihide Izumida, Koichiro Kinugawa, Riona Yamamoto, Teruhiko Imamura, Naoya Kataoka   +4 more
core   +1 more source

Impact of Once-Daily Ivabradine on Average Resting Heart Rate in Patients With Reduced Ejection Fraction With Systolic Dysfunction: A Multicenter, Post-marketing Observational Study. [PDF]

Cureus
Mullasari A, Abdullakutty J, Suryavanshi S, Gadkari MA, Aggrawal RK, Sable A, Sawant P.   +6 more
europepmc   +1 more source

A sustainable spectrofluorimetric method for ivabradine quantification based on erythrosin B quenching with quantum mechanical modeling and Box-Behnken design optimization. [PDF]

RSC Adv
Alqahtani AS, Abduljabbar MH, Alnemari RM, Althobaiti MM, Aldawsari MF, Al-Mutairi AA, Serag A, Almalki AH.   +7 more
europepmc   +1 more source

Maximizing treatment response in patients with neuropathic-subtype postural orthostatic tachycardia syndrome. [PDF]

Front Neurol
Rilinger RG, Chin AY, Cantrell C, Levine M, Stallkamp Tidd SJ, Wilson R.   +5 more
europepmc   +1 more source

Potential use of ivabradine in postoperative junctional ectopic tachycardia: a systematic review and single-arm meta-analysis. [PDF]

BMC Cardiovasc Disord
Balweel H, Immanuel SS, Budiono J, Cusan C, Gotama JE, Tafriend NA, Harsoyo A.   +6 more
europepmc   +1 more source